Activation of p16 leads to the inhibition of the cyclin-dependent kinases CDK4/6 and CDK2, which play a vital role in cell cycle regulation and are implicated in various physiological processes like cancer, tissue regeneration, aging, cellular senescence, and development [31]. This evidence concerns the gene CDKN2A and cancer.